Shandong Realcan Pharmaceutical Co Ltd Cash Flow Quality Index
Shandong Realcan Pharmaceutical Co Ltd cash flow quality index. Shandong Realcan Pharmaceutical Co Ltd (002589) has a Cash Flow Quality Index of 6.22x as of June 2025. Operating cash flow of CN¥24.86 Million exceeds net income of CN¥4.00 Million, indicating high earnings quality where cash backs reported profits. Explore Shandong Realcan Pharmaceutical Co Ltd (002589) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shandong Realcan Pharmaceutical Co Ltd (2008–2025)
Cash flow quality index of Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2025. Historical Cash Flow Quality Index for Shandong Realcan Pharmaceutical Co Ltd across 16 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Shandong Realcan Pharmaceutical Co Ltd (002589) balance sheet quality index to measure how much of total assets are equity-financed.
Shandong Realcan Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2008–2025)
Shandong Realcan Pharmaceutical Co Ltd cash flow quality index by year from 2008 to 2025. Year-by-year earnings quality comparison for Shandong Realcan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Shandong Realcan Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.86x | CN¥13.76 Million | CN¥16.07 Million | ▼ -78.1% |
| 2024 | 3.91x | CN¥160.44 Million | CN¥41.02 Million | ▼ -3.6% |
| 2023 | 4.06x | CN¥82.47 Million | CN¥20.32 Million | ▲ +250.0% |
| 2021 | 1.16x | CN¥442.95 Million | CN¥382.01 Million | ▲ +74.5% |
| 2020 | 0.66x | CN¥414.96 Million | CN¥624.55 Million | ▲ +521.0% |
| 2018 | -0.16x | CN¥-201.66 Million | CN¥1.28 Billion | ▲ +91.1% |
| 2017 | -1.77x | CN¥-2.42 Billion | CN¥1.37 Billion | ▲ +32.1% |
| 2016 | -2.61x | CN¥-1.76 Billion | CN¥675.07 Million | ▼ -35.9% |
| 2015 | -1.92x | CN¥-466.26 Million | CN¥243.13 Million | ▼ -113.0% |
| 2014 | -0.90x | CN¥-163.62 Million | CN¥181.76 Million | ▲ +52.7% |
| 2013 | -1.90x | CN¥-274.46 Million | CN¥144.24 Million | ▼ -23.5% |
| 2012 | -1.54x | CN¥-170.52 Million | CN¥110.67 Million | ▲ +72.7% |
| 2011 | -5.65x | CN¥-475.03 Million | CN¥84.02 Million | ▼ -597.9% |
| 2010 | 1.14x | CN¥70.56 Million | CN¥62.13 Million | ▼ -17.1% |
| 2009 | 1.37x | CN¥61.38 Million | CN¥44.81 Million | ▲ +180.1% |
| 2008 | -1.71x | CN¥-49.88 Million | CN¥29.18 Million | — |